Jacobs Levy Equity Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-333,593
| Closed | -$457K | – | 965 |
|
|
2023
Q3 | $457K | Buy |
333,593
+9,437
| +3% | +$12.9K | ﹤0.01% | 820 |
|
|
2023
Q2 | $788K | Buy |
324,156
+47,393
| +17% | +$115K | ﹤0.01% | 742 |
|
|
2023
Q1 | $1.59M | Buy |
276,763
+207,381
| +299% | +$1.19M | 0.01% | 614 |
|
|
2022
Q4 | $620K | Buy |
+69,382
| New | +$620K | ﹤0.01% | 752 |
|
|
2022
Q1 | – | Sell |
-27,497
| Closed | -$481K | – | 993 |
|
|
2021
Q4 | $481K | Hold |
27,497
| – | – | ﹤0.01% | 839 |
|
|
2021
Q3 | $216K | Hold |
27,497
| – | – | ﹤0.01% | 980 |
|
|
2021
Q2 | $283K | Hold |
27,497
| – | – | ﹤0.01% | 939 |
|
|
2021
Q1 | $360K | Hold |
27,497
| – | – | ﹤0.01% | 908 |
|
|
2020
Q4 | $386K | Hold |
27,497
| – | – | ﹤0.01% | 883 |
|
|
2020
Q3 | $327K | Buy |
+27,497
| New | +$327K | ﹤0.01% | 876 |
|